Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 An enhanced recovery protocol decreases complication rates in high-risk gynecologic oncology patients undergoing non-emergent laparotomyInternational Journal of Gynecological Cancer.  31:647-655. 2021
2021 Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: The sgo minimally invasive academy surgical curriculumJournal of Gynecologic Oncology.  32:1-7. 2021
2021 Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancerCancer Medicine.  10:709-717. 2021
2020 Decreasing opioid use in postoperative gynecologic oncology patients through a restrictive opioid prescribing algorithmGynecologic Oncology.  159:773-777. 2020
2020 Niraparib maintenance in frontline management of ovarian cancer: A cost effectiveness analysisInternational Journal of Gynecological Cancer.  30:1569-1575. 2020
2020 Reducing emergency department (ED) computed tomography (CT) utilization in women treated for gynecologic cancersGynecologic Oncology.  156:288-292. 2020
2020 The financial impact of an enhanced recovery after surgery (ERAS) protocol in an academic gynecologic oncology practiceGynecologic Oncology.  156:284-287. 2020
2019 Pyridoxine for prevention and treatment of PARP inhibitor induced nausea and vomitingGynecologic Oncology Reports.  29:123-125. 2019
2019 Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysisGynecologic Oncology.  153:381-384. 2019
2018 The antitumor effects of entinostat in ovarian cancer require adaptive immunityCancer.  124:4657-4666. 2018
2018 Enhanced Recovery After Surgery in Surgical Specialties: Gynecologic OncologySurgical Clinics of North America.  98:1275-1285. 2018
2018 Impact of enhanced recovery after surgery (ERAS) protocol on gastrointestinal function in gynecologic oncology patients undergoing laparotomyGynecologic Oncology.  151:282-286. 2018
2018 Treatment of low-grade endometrial stromal sarcoma in a nulligravid womanGynecologic Oncology.  151:6-9. 2018
2018 Predictors of Unplanned Reoperation for Ovarian Cancer Patients from the National Surgical Quality Improvement Program DatabaseInternational Journal of Gynecological Cancer.  28:1427-1431. 2018
2018 Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma 2018
2017 The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysisGynecologic Oncology.  146:642-646. 2017
2017 Malignant Brenner tumor associated with a germline BRCA2 mutationGynecologic Oncology Reports.  21:17-19. 2017
2017 Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical reviewGynecologic Oncology Reports.  20:81-86. 2017
2017 Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growthOncotarget.  8:44159-44170. 2017
2016 Early warning score: An indicator of adverse outcomes in postoperative patients on a gynecologic oncology serviceGynecologic Oncology.  143:105-108. 2016
2016 See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?Journal of Lower Genital Tract Disease.  20:243-246. 2016
2015 PARP inhibitor maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: A cost-effectiveness analysisGynecologic Oncology.  139:59-62. 2015
2013 Perioperative morbidity and mortality in octogenarians with ovarian cancerInternational Journal of Gynecological Cancer.  23:1006-1009. 2013
2012 Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapyGynecologic Oncology.  126:69-72. 2012

Chapter

Year Title Altmetric
2014 A 65-year-old woman with new-onset fatigue, parasthesias, and muscle cramps after chemotherapy for ovarian cancer.  294-296. 2014

Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 2012
  • Bachelor of Science or Mathematics in Biology, Birmingham-Southern College 2008
  • Full Name

  • Haller Smith